Lilly Sues Invagen Over Osteoporosis Drug Evista
Eli Lilly & Co. has sued InvaGen Pharmaceuticals Inc. over its attempt to make a generic version of the osteoporosis drug Evista, a Lilly drug at the center of another long-running...To view the full article, register now.
Already a subscriber? Click here to view full article